Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay

[1]  N. LeBrasseur,et al.  Regenerating skeletal muscle in the face of aging and disease. , 2014, American journal of physical medicine & rehabilitation.

[2]  K. Vaswani,et al.  Method Development for the Detection of Human Myostatin by High-Resolution and Targeted Mass Spectrometry. , 2014, Journal of proteome research.

[3]  T. Hornberger,et al.  Faculty Opinions recommendation of Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. , 2014 .

[4]  N. LeBrasseur,et al.  Myostatin and Sarcopenia: Opportunities and Challenges - A Mini-Review , 2014, Gerontology.

[5]  B. Lin,et al.  Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders , 2013, Current opinion in supportive and palliative care.

[6]  Ravi Kumar,et al.  A single ascending‐dose study of muscle regulator ace‐031 in healthy volunteers , 2013, Muscle & nerve.

[7]  N. LeBrasseur,et al.  Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin‐like growth factor binding protein‐2 levels in adult women and men , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  T. Dschietzig,et al.  Plasma myostatin measured by a competitive ELISA using a highly specific antiserum. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[9]  Der-Sheng Han,et al.  Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome. , 2012, Human reproduction.

[10]  T. Dschietzig,et al.  Endocrine and clinical correlates of myostatin serum concentration in men--the STRAMBO study. , 2012, The Journal of clinical endocrinology and metabolism.

[11]  Der-Sheng Han,et al.  Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis , 2011, Clinical endocrinology.

[12]  L. Ferrucci,et al.  International working group on Sarcopenia , 2011 .

[13]  F. Gilbert,et al.  Serum concentrations of myostatin and myostatin-interacting proteins do not differ between young and sarcopenic elderly men. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  Sandrine Andrieu,et al.  Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. , 2011, Journal of the American Medical Directors Association.

[15]  W. Mitch,et al.  Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  L. Melton,et al.  Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  S. Mosler,et al.  Analysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive Immuno PCR , 2010, Molecular and Cellular Endocrinology.

[18]  B. Larijani,et al.  Effects of oral creatine and resistance training on serum myostatin and GASP-1 , 2010, Molecular and Cellular Endocrinology.

[19]  C. Mammucari,et al.  Smad2 and 3 transcription factors control muscle mass in adulthood. , 2009, American journal of physiology. Cell physiology.

[20]  S. Hatakeyama,et al.  Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. , 2009, American journal of physiology. Cell physiology.

[21]  A. Dorner,et al.  Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administration , 2009, Molecular and Cellular Endocrinology.

[22]  N. LeBrasseur,et al.  Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[23]  A. Goldberg,et al.  Identification of a Novel Pool of Extracellular Pro-myostatin in Skeletal Muscle* , 2008, Journal of Biological Chemistry.

[24]  B. Riggs,et al.  Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density , 2008, Osteoporosis International.

[25]  Jennifer J Westendorf,et al.  Building bone to reverse osteoporosis and repair fractures. , 2008, The Journal of clinical investigation.

[26]  E. Engvall,et al.  Gross muscle hypertrophy in whippet dogs is caused by a mutation in the myostatin gene , 2007, Neuromuscular Disorders.

[27]  A. Oberg,et al.  Does Reduced Skeletal Loading Account for Age‐Related Bone Loss? , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  B. Langley,et al.  Proteolytic processing of myostatin is auto-regulated during myogenesis. , 2005, Developmental biology.

[29]  W. Bullough.  The actions of the chalones , 1971, Agents and Actions.

[30]  W. N. Pappano,et al.  Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Hewick,et al.  Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. , 2003, Molecular endocrinology.

[32]  Denise M O'Hara,et al.  Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. , 2003, Biochemical and biophysical research communications.

[33]  R. Ahima,et al.  Functional improvement of dystrophic muscle by myostatin blockade , 2002, Nature.

[34]  R. Hewick,et al.  The Myostatin Propeptide and the Follistatin-related Gene Are Inhibitory Binding Proteins of Myostatin in Normal Serum* , 2002, The Journal of Biological Chemistry.

[35]  K. Yarasheski,et al.  Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. , 2002, The journal of nutrition, health & aging.

[36]  B E Ainsworth,et al.  Compendium of physical activities: an update of activity codes and MET intensities. , 2000, Medicine and science in sports and exercise.

[37]  Se-Jin Lee,et al.  Myostatin and the control of skeletal muscle mass. , 1999, Current opinion in genetics & development.

[38]  K. Matthews,et al.  Myostatin, a transforming growth factor‐β superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct , 1999, Journal of cellular physiology.

[39]  A. Joyner,et al.  Expression of growth/differentiation factor 11, a new member of the BMP/TGFβ superfamily during mouse embryogenesis , 1999, Mechanisms of Development.

[40]  G G Klee,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Relationship of Serum Sex Steroid Levels and Bone Turnover Markers with Bone Mineral Density in Men and Women: A Key Role for Bioavailable Estroge , 2022 .

[41]  Se-Jin Lee,et al.  Double muscling in cattle due to mutations in the myostatin gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Paffenbarger,et al.  Physical activity as an index of heart attack risk in college alumni. , 1978, American journal of epidemiology.

[43]  W. Bullough.  THE CONTROL OF MITOTIC ACTIVITY IN ADULT MAMMALIAN TISSUES , 1962, Biological reviews of the Cambridge Philosophical Society.